TA-65, A Telomerase Activator improves Cardiovascular Markers in Patients with Metabolic Syndrome
Year: 2018
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Current Pharmaceutical Design
Institution: University of Connecticut
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2790524041
